HANNAH DEHERTOGH: Open Payments
NPI 1417681818 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,032 in 46 payments from 18 companies in 2025. Trend: 2023 $741 · 2024 $835 · 2025 $1,032
Food & beverage: $1,032
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $323 |
| Actelion Pharmaceuticals US, Inc. | 3 | $109 |
| Exact Sciences Corporation | 3 | $88 |
| Lundbeck LLC | 3 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Kowa Pharmaceuticals America, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $24 |
Products named: Wegovy, REXULTI, Cologuard Collection Kit, OPSUMIT, JARDIANCE, Ozempic, XIFAXAN, Rybelsus.
Industry payments across CT — which companies pay providers there.
